PMV Pharmaceuticals Inc (PMVP)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -55.274 | -30.454 | -14.7 | -16.596 | -24.363 | -26.398 |
Return on Equity (%) | 76.021 | 43.48 | -23.863 | -17.327 | -26.44 | -29.238 |
Return on Invested Capital (%) | -62.066 | -33.485 | -15.289 | -17.934 | -28.816 | -36.16 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 20.282 | 32.324 | 8.02 | 6.792 | 5.375 | 4.387 |
Earnings Per Share | -5.823 | -8.323 | -0.769 | -1.273 | -1.602 | -1.34 |
Cash Per Share | 10.062 | 24.057 | 8.071 | 3.796 | 2.366 | 0.733 |
Working Capital Per Share | 19.891 | 32.032 | 8.003 | 6.363 | 5.16 | 3.759 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -5.822 | -8.32 | -0.769 | -1.273 | -1.602 | -1.34 |
EBITDA Per Share | -5.822 | -8.32 | -0.769 | -1.273 | -1.602 | -1.34 |
Free Cash Flow Per Share | -5.785 | -8.585 | -0.773 | -1.25 | -1.434 | -1.346 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 3,01M | 3,05M | 44,78M | 45,43M | 45,77M | 51,45M |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 45,77M | N/A | N/A | N/A | 51,45M | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 78,14M |
Ratio cours/bénéfice | -1,08 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 1,98 |
Ratio prix/valeur comptable | 0,33 |
Rendement de dividende | - |
Actions en circulation | 51,75M |
Volume moyen (1 semaine) | 116,01k |
Volume moyen (1 mois) | 152,21k |
Variation sur 52 semaines | -44,62% |
Plus haut sur 52 semaines | 2,72 |
Plus bas sur 52 semaines | 1,40 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales